GLP-1 Research
More than 25% of weight lost on semaglutide can come from lean muscle mass — here is what…
A research-backed breakdown of semaglutide's safety and efficacy for type 2 diabetes and weight loss, including side effects,…
A PubMed-backed breakdown of how GLP-1 medications reshape metabolic health, what the real-world data actually shows about their…
Ozempic's maximum approved dose is 2 mg weekly for diabetes and 2.4 mg weekly for weight loss under…
Semaglutide exists under three brand names — Ozempic, Wegovy, and Rybelsus — each with distinct doses, delivery methods,…
Semaglutide (Ozempic) can be used by non-diabetic men off-label or through Wegovy, but clinical evidence shows results depend…
Tirzepatide's dual GIP/GLP-1 receptor mechanism delivers unprecedented weight loss outcomes, but the science also reveals critical muscle preservation…
A deep dive into the clinical evidence behind Ozempic for type 2 diabetes — how it works, what…
GLP-1 medications like semaglutide and tirzepatide can cause the equivalent of 20 years of muscle loss — here's…
New research reveals GLP-1 medications may improve testosterone levels in men with metabolic dysfunction — but the mechanism…